The effect of fenofibrate for seizure control in epilepsy patients

Phase 2

• Conditions: Refractory epilepsy.; Epilepsy, unspecified, intractable; G40.91

• Registration Number: IRCT20200825048515N63
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Epilepsy patients
Age more than 18 years
Resistant to at least two anticonvulsants
Having seizures on average twice a month or more
Consent to participate in the study

Exclusion Criteria

Concurrent liver and kidney disease and hyperlipidemia
Atorvastatin drug use

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of seizure attacks. Timepoint: Before and after the intervention. Method of measurement: Seizure attack frequency.;EEG changes. Timepoint: Before and after the intervention. Method of measurement: Electrocardiogram (ECG).